Biologic agents and tuberculosis

Claudia C. Dobler*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

1 Citation (Scopus)

Abstract

In recent years, the market of biopharmaceuticals has been growing at a fast pace due to increased availability of targets for biologic agents, approval of biologic agents for new and expanded indications, and increased use of these medications. Biopharmaceuticals, also known as biologic products or agents, biologics, or biologicals, are drugs that are produced through biological processes rather than chemical synthesis. These include recombinant proteins, monoclonal and polyclonal antibodies, peptides, antisense oligonucleotides, therapeutic genes, and recombinant and DNA vaccines. Biopharmaceuticals usually require infusion or injection rather than oral application.

Original languageEnglish
Title of host publicationTuberculosis and Nontuberculous Mycobacterial Infections
EditorsDavid Schlossberg
PublisherWiley-Liss
Chapter37
Pages623-635
Number of pages13
Edition7th
ISBN (Electronic)9781683670605
ISBN (Print)9781555819859
DOIs
Publication statusPublished - 27 Apr 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Biologic agents and tuberculosis'. Together they form a unique fingerprint.

Cite this